Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

When should an indwelling pleural catheter be considered for malignant pleural effusion?

Abdul Hamid Alraiyes, MD, FCCP, Kassem Harris, MD, FCCP and Thomas R. Gildea, MD, MS, FCCP
Cleveland Clinic Journal of Medicine December 2016, 83 (12) 891-894; DOI: https://doi.org/10.3949/ccjm.83a.15075
Abdul Hamid Alraiyes
Interventional Pulmonary Secton, Co-Director of Pleural Disease, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Kassem Harris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas R. Gildea
Head, Section of Bronchoscopy, Respiratory Institute, Department of Pulmonary, Allergy, and Critical Care Medicine and Transplant Center, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Draining of a pleural effusion in the left hemithorax. The indwelling pleural catheter is tunneled under the soft tissue and enters the thoracic cavity between the ribs. Proximally, the catheter has a one-way valve and evacuates into a negative-pressure bottle.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Tunneling the indwelling pleural catheter under the soft tissue of the chest wall before insertion in the pleural cavity. The procedure can be performed at the bedside under sterile conditions. The site of the insertion is identified with thoracic ultrasonography. (A), The guide wire is inserted at the thoracic inlet area, then (b) the catheter is tunneled under the skin to the guide wire area for insertion.

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Computed tomography of the chest demonstrates (A) left malignant pleural effusion secondary to adenocarcinoma of the lung, and (B) trapped lung (black arrow) after placement of an indwelling pleural catheter (white arrow) in the same patient.

Tables

  • Figures
    • View popup
    TABLE 1

    Management of malignant pleural effusions

    ProcedureIndication
    Repeated thoracentesisFirst presentation with pleural effusion
    Chest tube drainage and talc pleurodesisMassive pleural effusion, empyema, and history of poor compliance
    Medical or surgical thoracoscopy and talc poudrageHospitalized patient with history of poor compliance
    Pleurectomy and decorticationMesothelioma
    Indwelling pleural catheterOutpatient recurrent malignant pleural effusion with respiratory symptoms
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 83 (12)
Cleveland Clinic Journal of Medicine
Vol. 83, Issue 12
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
When should an indwelling pleural catheter be considered for malignant pleural effusion?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
When should an indwelling pleural catheter be considered for malignant pleural effusion?
Abdul Hamid Alraiyes, Kassem Harris, Thomas R. Gildea
Cleveland Clinic Journal of Medicine Dec 2016, 83 (12) 891-894; DOI: 10.3949/ccjm.83a.15075

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
When should an indwelling pleural catheter be considered for malignant pleural effusion?
Abdul Hamid Alraiyes, Kassem Harris, Thomas R. Gildea
Cleveland Clinic Journal of Medicine Dec 2016, 83 (12) 891-894; DOI: 10.3949/ccjm.83a.15075
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • MALIGNANT PLEURAL EFFUSION
    • PLEURODESIS HAS BEEN THE TREATMENT OF CHOICE
    • PLACEMENT OF AN INDWELLING PLEURAL CATHETER
    • AN EFFECTIVE INITIAL TREATMENT
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • My adult patient’s hypercholesterolemia is not responding to statins—what’s next?
  • Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
  • Does my adult patient need a measles vaccine?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Hospice & Palliative Medicine
  • Oncology
  • Pulmonology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire